{"schema_version":"secwatch.filing_event.v1","accession":"0001746473-23-000062","form_type":"8-K","ticker":"PLRX","cik":"0001746473","company_name":"PLIANT THERAPEUTICS, INC.","filed_at":"2023-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.296458+00:00","generated_at":"2026-06-10T05:34:08.946811+00:00","sec_items":["1.01","1.02","2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pliant Therapeutics signs 7-year lease for 100,904 sq ft in South San Francisco, terminates old lease","bullets":["Leased 100,904 rentable sq ft at 331 Oyster Point Blvd, South San Francisco for 7-year initial term.","Base rent starts at $0.26M/month in year 1 (based on phased rentable sq ft) and rises to $0.71M/month in year 7.","Old lease at 260 Littlefield Ave will terminate 60 days after new lease commencement; no early termination penalties.","Required $1.43M letter of credit; Tenant responsible for operating expenses and has 8-year extension option.","Right of first offer on 33,333 sq ft on 2nd floor, subject to superior right of NGM Biopharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001746473-23-000062","json":"https://secwatch.observer/filing/0001746473-23-000062.json","markdown":"https://secwatch.observer/filing/0001746473-23-000062.md","text":"https://secwatch.observer/filing/0001746473-23-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/0001746473-23-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/plrx-20230928.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T05:34:08.946811+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"024e1c1392470151db87a0492929549fe69ba594","claim":"PLIANT THERAPEUTICS, INC. entered into Oyster Point Lease with HCP BTC, LLC valued at $0.26 million/month initial, $0.71 million/month final; 7 years; $1.43M letter of credit (effective 2023-09-28).","evidence_excerpt":"On September 28, 2023, Pliant Therapeutics, Inc., a Delaware Corporation (the “Company”) entered into a lease agreement (the “Oyster Point Lease”) with HCP BTC, LLC, a Delaware limited liability company (the “Landlord”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/0001746473-23-000062-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"lease"},{"label":"Counterparty","value":"HCP BTC, LLC"},{"label":"Value","value":"$0.26 million/month initial, $0.71 million/month final; 7 years; $1.43M letter of credit"},{"label":"Effective","value":"2023-09-28"}],"fact_type":"material_agreement"},{"claim_id":"a798bd9ad991a5bf77b1025fceef701d3d70498c","claim":"PLIANT THERAPEUTICS, INC. terminated Littlefield Lease Termination with Healthpeak OP, LLC valued at Termination 60 days after Oyster Point Lease commencement; no penalty (effective 2023-09-28).","evidence_excerpt":"In connection with the entry into the Oyster Point Lease, the Company entered into a termination agreement (the “Termination Agreement”) with Healthpeak OP, LLC, a Maryland limited liability company, successor-interest to HCP, Inc. (“Healthpeak”) with respect to the Company’s lease (the “Littlefield Lease”) of 260 Littlefield Avenue, South San Francisco, California 94080 (“Littlefield Premises”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/0001746473-23-000062-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"lease"},{"label":"Counterparty","value":"Healthpeak OP, LLC"},{"label":"Value","value":"Termination 60 days after Oyster Point Lease commencement; no penalty"},{"label":"Effective","value":"2023-09-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}